Related Experiment Video
Updated: Dec 24, 2025
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.8K
Myotonic disorders and pregnancy.
1Mater Health, University of Queensland, South Brisbane, Australia.
Obstetric Medicine
|April 15, 2020
Summary
Managing myotonic disorders during pregnancy requires careful planning and monitoring to prevent maternal and fetal complications. This involves pre-conception counseling, close surveillance, and a multidisciplinary team approach for delivery and postpartum care.
Area of Science:
- Obstetrics and Gynecology
- Neurology
- Medical Genetics
Background:
- Myotonic disorders pose significant risks during pregnancy, including potential maternal and fetal complications.
- Effective management necessitates a comprehensive strategy encompassing pre-conception, intrapartum, and postpartum care.
Purpose of the Study:
- To present a case of myotonia congenita diagnosed during pregnancy.
- To discuss general principles for managing pregnancies in women with myotonic disorders.
- To review the specific care requirements for these conditions during gestation.
Main Methods:
- Case report presentation.
- Review of established clinical guidelines for myotonic disorders in pregnancy.
- Discussion of multidisciplinary team approach in managing complex pregnancies.
Main Results:
- Myotonia congenita diagnosed in pregnancy requires specialized management.
- Pre-conception counseling is crucial for optimizing maternal and fetal outcomes.
- Close maternal and fetal monitoring throughout pregnancy is essential.
Conclusions:
- Pregnancies complicated by myotonic disorders demand meticulous, individualized care.
- A coordinated, multidisciplinary approach ensures optimal management from conception through the postpartum period.
- Early diagnosis and proactive planning are key to mitigating risks associated with myotonic disorders in pregnancy.
Related Concept Videos
01:28Disorders of the Skeletal Muscle
1.6K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.6K
01:22Isotonic and Isometric Muscle Contractions
6.2K
Two primary types of muscle contractions are isotonic and isometric, each serving unique functions and involving distinct mechanisms. Both isotonic and isometric contractions are integral to the body's complex system of movement and stability. Isotonic exercises contribute significantly to functional strength and movement, while isometric contractions are crucial for maintaining posture and joint stability.
Isotonic contractions
Isotonic contractions occur when a muscle changes length while...
Isotonic contractions
Isotonic contractions occur when a muscle changes length while...
6.2K
01:21Skeletal Muscle Relaxants: Adverse Effects
721
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
721
01:20Myasthenia Gravis: Overview and Treatment
2.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K
01:15Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.0K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.0K